Table 3.
Patient’s history
| All patients (n = 195) | Bleeding complications (N = 35) | No bleeding complications (N = 160) | p-value | |
|---|---|---|---|---|
| Insulin dependent diabetes mellitus N (%) | 51 (26) | 12 (34) | 39 (24) | 0.227 |
| Medication for arterial hypertonus N (%) | 103 (53) | 22 (63) | 1 (51) | 0.189 |
| History of thrombosis/embolism N (%) | 0.237 | |||
| Venous thrombosis | 6 (3) | 0 (0) | 6 (4) | |
| Lung artery embolism | 6 (3) | 0 (0) | 6 (4) | |
| Coronary heart disease/PAD | 14 (7) | 3 (9) | 11 (7) | |
| Ischemic stroke | 4 (2) | 2 (6) | 2 (1) | |
| History of bleeding N (%) | 4 (2) | 0 (0) | 4 (3) | 0.345 |
| History of liver disease N (%) | 13 (7) | 2 (6) | 11 (7) | 0.803 |
| History of alcohol abuse N (%) | 20 (10) | 3 (9) | 17 (11) | 0.717 |
| Preoperative anticoagulation N (%) | 0.501 | |||
| Platelet aggregation inhibitor | 23 (12) | 4 (11) | 19 (12) | |
| Coumarine derivatives | 3 (2) | 1 (3) | 2 (1) | |
| Other oral anticoagulation | 6 (3) | 1 (3) | 5 (3) | |
| Other | 4 (2) | 2 (6) | 2 (1) |
PAD: peripheral artery disease